Valuation
Valuation
Balance Sheet
Debt
Dividend
Profitability
Income
Investment
Visu uses AI to transform SEC filings and press releases into accurate summaries of earnings and key company events.
Mettler-Toledo Appoints New Independent Director Pablo Perversi
Mettler-Toledo International Inc. has appointed Pablo Perversi as a director, effective November 6, 2025. Mr. Perversi qualifies as an independent director under New York Stock Exchange standards, and the Board will increase its size from eight to nine directors. His compensation will align with that of other independent directors, and there are no disclosed arrangements or interests affecting his appointment.
Pablo Perversi currently serves as President of Europe at Danone and has extensive experience in the food industry, having held significant roles at Barry Callebaut and Unilever. His background includes over 30 years of leadership in global organizations, which the company believes will provide valuable insights. Mettler-Toledo is recognized for its position in precision instruments and services across various industries, including life sciences and food.
linkAug 04, 2025 16:37:43
Mettler-Toledo Reports Second Quarter Financial Results for 2025
Mettler-Toledo International Inc. reported a 4% increase in total sales for the second quarter of 2025, reaching $983.2 million. The company’s net earnings per diluted share (EPS) were $9.76, down from $10.37 in the prior year, but adjusted EPS rose by 5% to $10.09. Sales growth varied by region, with a 2% increase in the Americas, 6% in Europe, and 4% in Asia/Rest of World. For the first half of 2025, total sales remained flat at $1.867 billion, with adjusted EPS slightly decreasing by 1% to $18.27 compared to the previous year. Adjusted operating profit for the quarter was $283.3 million, slightly lower than the prior year’s $284.1 million.
The company anticipates local currency sales growth of approximately 3% to 4% for the third quarter and adjusted EPS between $10.55 and $10.75, reflecting a growth rate of 3% to 5%. Mettler-Toledo expects full-year local currency sales growth of 1% to 2% and adjusted EPS in the range of $42.10 to $42.60. The company has noted challenges from tariff costs and shipping delays but is implementing strategies to mitigate these impacts. Mettler-Toledo maintains a strong market position and continues to focus on innovation to drive growth.
linkJul 31, 2025 17:53:10
Mettler-Toledo Reports Decline in Sales and Earnings for Q1 2025
Mettler-Toledo International Inc. announced its first quarter results for 2025, reporting a 5% decline in total sales compared to the prior year, amounting to $883.7 million. In local currency, sales decreased by 3%, although they grew by 3% when excluding the impact of delayed shipments from the previous year. Net earnings per diluted share were reported at $7.81, down from $8.24 in the same period last year. The company experienced regional sales declines of 2% in the Americas, 9% in Europe, and 4% in Asia/Rest of World.
Adjusted earnings per share for the quarter were $8.19, representing an 8% decrease from $8.89 in the prior-year period. The company's adjusted operating profit also decreased to $236.7 million from $267.3 million year-over-year. Management indicated uncertainty in market conditions, projecting local currency sales for the second quarter to increase by approximately 0% to 1%. Additionally, they expect adjusted EPS for the full year 2025 to be in the range of $41.25 to $42.00, reflecting potential headwinds from tariffs and previous shipping delays.
linkMay 01, 2025 17:02:22
Mettler-Toledo Reports 12% Sales Growth in Q4 2024
Mettler-Toledo International Inc. reported a 12% increase in sales for the fourth quarter of 2024, totaling $1.045 billion. Net earnings per diluted share rose to $11.96, a 40% increase from $8.52 in the previous year. The company's adjusted EPS also saw a significant rise of 32%, reaching $12.41. Sales growth varied by region, with Europe experiencing the highest increase at 18%, followed by Asia/Rest of World at 15%, and the Americas at 6%. The company attributed this growth to strong customer demand for laboratory products, particularly in Europe, and effective margin improvement initiatives. Adjusted operating profit also increased by 25% compared to the prior year, totaling $351.9 million in Q4 2024.
On the downside, Mettler-Toledo faced challenges with delayed shipments from the previous quarter, which impacted local currency sales growth. For the full year 2024, total reported sales only increased by 2%, with a decline of 3% in Asia/Rest of World. The company anticipates a decline in local currency sales of approximately 3% to 4% for the first quarter of 2025 due to these shipping delays. Additionally, management cautioned about uncertain market conditions that could affect future performance, indicating a forecasted adjusted EPS decline of 11% to 13% for the upcoming quarter.
linkFeb 06, 2025 16:41:24
Mettler-Toledo Reports $9.96 EPS for Q3 2024
Mettler-Toledo International Inc. announced a 1% increase in reported sales for the third quarter of 2024, totaling $954.5 million. The company reported a net earnings per diluted share of $9.96, up from $9.21 in the previous year, and an adjusted EPS of $10.21, marking a 4% increase. Growth was particularly noted in the Laboratory business and Service sector, with European sales rising by 2% and Asia/Rest of World by 4%. However, sales in the Americas declined by 1%, reflecting challenging market conditions, especially in the Industrial sector. Adjusted operating profit remained relatively flat at $296.6 million compared to the prior year.
On the downside, total reported sales for the nine months ending September 30, 2024, decreased by 1% to $2.827 billion, with a notable 8% decline in Asia/Rest of World sales. Year-to-date adjusted operating profit also saw a decrease of 3% compared to the previous year. The company noted that while they are pleased with their growth initiatives, global market conditions remain soft, indicating potential challenges ahead.
linkNov 07, 2024 16:39:20
Mettler-Toledo Reports Mixed Q2 Results Amid Currency Challenges
Mettler-Toledo's Q2 sales fell 4% year-over-year, with a notable 16% decline in Asia. However, net earnings per share rose to $10.37, aided by a one-time tax benefit. The company saw growth in Europe and the Americas but cautioned about uncertain market conditions, particularly in China. Adjusted EPS decreased by 5%. Looking ahead, Mettler-Toledo anticipates slight growth in local currency sales and adjusted EPS for Q3, while full-year forecasts remain stable despite currency headwinds.
linkAug 01, 2024 16:40:06
Brian Shepherd Joins Mettler Toledo Board of Directors
Mettler-Toledo International Inc. welcomed Brian Shepherd to its Board of Directors, bringing extensive leadership experience in industrial automation and Smart Factory solutions. The company sees his expertise in data analytics and strategic execution as valuable for their growth. Mettler Toledo is a global leader in precision instruments and services, with a strong market position and a focus on innovation and customer solutions in various industries. The addition of Shepherd is expected to enhance the company's strategic direction.
linkJun 26, 2024 16:24:17
Mettler-Toledo Q1 2024 Results: Flat Sales, Slight EPS Increase
Mettler-Toledo International Inc. reported flat sales in Q1 2024, with a 6% boost from recovering delayed shipments. Net earnings per share slightly decreased, but adjusted EPS increased by 2%. Despite market challenges, the company managed to grow adjusted operating profit. However, for Q2 2024, they expect a 4% sales decline and an 11-13% drop in adjusted EPS. Full-year forecast includes a 2% sales increase and 5-6% growth in adjusted EPS, with currency headwinds affecting results.
linkMay 09, 2024 16:50:36
Mettler-Toledo International Inc. Reports Fourth Quarter 2023 Results
Mettler-Toledo International Inc. reported a 12% decline in sales compared to the prior year, with net earnings per diluted share decreasing by 22%. The company faced challenges due to shipping delays and challenging market conditions. The full-year results also showed a decline in sales and adjusted EPS. The company anticipates a decline in sales and adjusted EPS for the first quarter of 2024, with increased uncertainty in the economic environment.
linkFeb 08, 2024 17:10:06
Patrick Kaltenbach, CEO at JP Morgan Healthcare Conference
Patrick Kaltenbach, CEO, presented forward-looking statements at the JP Morgan Healthcare Conference, addressing potential risks and uncertainties.
linkJan 10, 2024 08:01:25